Macrophages in Immunopathology of Atherosclerosis: A Target for Diagnostics and Therapy

Author(s): Alexander N. Orekhov, Igor A. Sobenin, Mikhail A. Gavrilin, Alexei Gratchev, Svetlana Y. Kotyashova, Nikita G. Nikiforov, Julia Kzhyshkowska

Journal Name: Current Pharmaceutical Design

Volume 21 , Issue 9 , 2015

Become EABM
Become Reviewer
Call for Editor


Immunopathology plays important roles in the development of different life-threatening diseases, such as atherosclerosis and its consequences (acute myocardial infarction and stroke), cancer, chronic inflammatory diseases. Effective modulation of the immune system may significantly increase the efficacy of prevention and therapy efforts. Currently there are no marketed drugs capable of normalizing immune system function in an intrinsic and comprehensive way. Here, we describe a test system designed for complex analysis of monocyte activity in individuals to diagnose immunopathology and monitor treatment efficacy. This cell-based test system may also be useful for screening compounds with an immune-correcting effects. Both diagnostic and screening systems are based on primary culture of human monocytes and/or monocyte-derived macrophages. This is the first step in creating a method for assessment of macrophage activity, which is required for further development of immune-correcting drugs. The existing preliminary data provide the basis for realization of this idea.

Keywords: Activation, atherosclerosis, chemokine, cytokine, diagnostics, immunopathology, macrophage, therapy.

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 13 October, 2014
Page: [1172 - 1179]
Pages: 8
DOI: 10.2174/1381612820666141013120459

Article Metrics

PDF: 97